Highlights Viveve Medical, Inc.

Equities

VIVE

US92852W5013

Delayed OTC Markets Other stock markets 13:36:25 2024-05-09 EDT			5-day change	1st Jan Change
0.0003 ^USD	0.00%		0.00%	+50.00%

2023	InMode Ltd. acquired Intellectual Property Assets of Viveve Medical Inc.	CI
2023	Viveve Medical, Inc.(OTCPK:VIVE) dropped from S&P TMI Index	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

InMode Ltd. acquired Intellectual Property Assets of Viveve Medical Inc.	23-07-24	CI
Weak China GDP Data Weigh on Exchange-Traded Funds, Equity Futures Premarket Tuesday	23-01-17	MT
Viveve Medical Fails to Meet Primary Endpoint in Stress Urinary Incontinence Study; Unveils Cut in Workforce; Expects Delisting From Nasdaq	23-01-17	MT
Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence	23-01-17	CI
Viveve Medical, Inc. Announces Completion of Pivotal US Pursuit Trial for Female Stress Urinary Incontinence	22-12-15	CI
Viveve Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
Earnings Flash (VIVE) VIVEVE MEDICAL Posts Q3 Revenue $1.7M	22-11-10	MT
Viveve Medical, Inc. Announces Notice of Allowance for Second U.S. Method Patent for Treating Female Stress Urinary Incontinence	22-10-04	CI
Viveve Medical, Inc. Launches Rebranding Initiative to Reflect Focus on Treatment of Female Stress Urinary Incontinence in Anticipation of U.S. Pivotal Pursuit Trial Readout	22-09-27	CI
Viveve Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
Earnings Flash (VIVE) VIVEVE MEDICAL Posts Q2 Revenue $1.8M, vs. Street Est of $1.76M	22-08-11	MT
Viveve Medical Says Taiwan Intellectual Property Office Awarded Patent for Viveve's Dual-Energy Technology	22-07-12	MT
Earnings Flash (VIVE) VIVEVE MEDICAL Reports Q1 Revenue $1.6M, vs. Street Est of $1.61M	22-05-12	MT
Viveve Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
Viveve Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-17	CI
Viveve Medical Completes Enrollment in Bladder Control Trial	21-12-14	MT
Viveve Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-12	CI
Earnings Flash (VIVE) VIVEVE MEDICAL Posts Q3 Revenue $1.6M, vs. Street Est of $1.69M	21-11-11	MT
Viveve Medical, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-12	CI
Viveve Medical : Earnings Flash (VIVE) VIVEVE MEDICAL Posts Q2 Revenue $1.65B	21-08-12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Viveve Medical, Inc.

Equities

VIVE

US92852W5013

Highlights

Filters